Assistant Professor of Medicine
Nephrology
Dr. Bernard G. Jaar, MD
|
|
Give Review
Bernard Jaar is an expert in the field of Nephrology. He over the years received 1 awards: "Fellow (ASNF)". Doctor Bernard G. Jaar, MD is a published doctor and has 88 publications published. The lastest was: 'Effects of long-term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation.' He accepts all Medicare patients.
Publications
- Sex Differences in the Incidence of Peripheral Artery Disease in the Chronic Renal Insufficiency Cohort.
- Frailty and Cognitive Function in Incident Hemodialysis Patients.
- Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.
- Intravenous Iron Exposure and Mortality in Patients on Hemodialysis.
- Age and sex disparities in discussions about Kidney transplantation in adults undergoing dialysis.
- An instrumental variable approach finds no associated harm or benefit With early dialysis initiation in the United States.
- Biomarkers of Vascular Calcification and Mortality in Patients With ESRD.
- Associations of multiple metals with Kidney outcomes in lead workers: author response.
- Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.
- Frailty as a Novel Predictor of Mortality and Hospitalization in Individuals of All Ages Undergoing Hemodialysis.
- Uranium associations with Kidney outcomes vary by urine concentration adjustment method.
- Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor Kidney transplantation: a randomiz...
- Selecting Renal replacement therapies: what do African American and non-African American patients and their families think others should know? A mixed methods study.
- Activity of daily living disability and dialysis mortality: better prediction using metrics of aging.
- Does Calcium Disodium EDTA Slow CKD Progression?
- Disparities in provision of transplant education by profit status of the dialysis center.
- Early assessment and targeted education is imperative in assuring equal, timely access to Kidney transplantation.
- ACP Journal Club: review: antiplatelet therapy does not reduce mortality in chronic Kidney disease.
- Associations of multiple metals with Kidney outcomes in lead workers.
- African american and non-african american patients' and families' decision making about Renal replacement therapies.
- Access to health care among adults evaluated for CKD: findings from the Kidney Early Evaluation Program (KEEP).
- Disparities in provision of transplant information affect access to Kidney transplantation.
- Risk prediction models in chronic Kidney disease: time to adopt a new paradigm?
- Associations of blood lead With estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations.
- Differences in urine cadmium associations with Kidney outcomes based on serum creatinine and cystatin C.
- The Achilles Heel of Mortality Risk by Dialysis Modality is Selection Bias.
- Albuminuria: Is it Time to Screen the General Population?
- Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.
- Identifying and addressing barriers to African American and non-African American families' discussions about preemptive living related Kidney transplantation.
- Associations of low-level urine cadmium with Kidney function in lead workers.
- The Case ∣ an age-old enemy should not be forgotten.
- Soluble P-selectin levels are associated With cardiovascular mortality and sudden cardiac death in male dialysis patients.
- Primary care-specialist collaboration in the care of patients with chronic Kidney disease.
- Effect of primary care physicians'' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions.
- Urinary biomarkers in Acute kidney transplant dysfunction.
- Association of social support With outcomes in incident dialysis patients.
- Association of residual urine output With mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring fo...
- Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature.
- Blood cadmium and lead and chronic Kidney disease in US adults: a joint analysis.
- Inpatient hemodialysis initiation: reasons, risk factors and outcomes.
- Peripheral vascular Disease-related procedures in dialysis patients: predictors and prognosis.
- Cerebrovascular Disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study.
- Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians.
- Preventing repeat hospitalizations in dialysis patients: a call for action.
- Association of peritoneal dialysis clinic size With clinical outcomes.
- Association of single-nucleotide polymorphisms in JAK3, STAT4, and STAT6 With new cardiovascular events in incident dialysis patients.
- Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study.
- Longitudinal associations between lead dose and Renal function in lead workers.
- Racial differences in chronic Kidney disease incidence and progression among individuals with HIV.
- The association of sudden cardiac death With inflammation and other traditional risk factors.
- Serum phosphate levels and risk of Infection in incident dialysis patients.
- Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
- Principles of screening for chronic Kidney disease.
- Novel and traditional cardiovascular risk factors for peripheral arterial Disease in incident-dialysis patients.
- Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
- Relation between level or change of hemoglobin and generic and Disease-specific quality of life measures in hemodialysis.
- Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study.
- Lead-related nephrotoxicity: a review of the epidemiologic evidence.
- Effect modification by delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase gene polymorphisms on associations between patella lead and...
- Association of clinic vascular access monitoring practices With clinical outcomes in hemodialysis patients.
- Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular Disease in dialysis patients.
- Identification and referral of patients With progressive CKD: a national study.
- Changes in serum Calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.
- Associations of uric acid With polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers.
- Use of dialysis educators beyond nurses and physicians and outcomes in patients with Kidney failure.
- Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic Kidney disease.
- High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
- Frequency of patient-physician contact in chronic Kidney disease care and achievement of clinical performance targets.
- Associations of patella lead and other lead biomarkers With renal function in lead workers.
- Combined percutaneous mechanical and chemical thrombectomy for renal vein thrombosis in Kidney transplant recipients.
- Associations among lead dose biomarkers, uric acid, and Renal function in Korean lead workers.
- High-dose mycophenolate mofetil in the treatment of posttransplant glomerular Disease in the allograft: a case series.
- Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients.
- Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.
- Screening for proteinuria in US adults: a cost-effectiveness analysis.
- Risk factors for chronic Kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland.
- Percutaneous mechanical thrombectomy: a new approach in the treatment of Acute renal-vein thrombosis.
- Septicemia in diabetic hemodialysis patients: comparison of incidence, risk factors, and mortality With nondiabetic hemodialysis patients.
- Septicemia in dialysis patients: incidence, risk factors, and prognosis.
- Further trends in the etiology of end-stage renal Disease in African-Americans.
- Thrombosis of angioaccess in haemodialysed patients treated With human recombinant erythropoietin.
- Effects of long-term treatment With recombinant human erythropoietin on physiologic inhibitors of coagulation.
- Efficacy of recombinant human erythropoietin in the treatment of refractory Anemias without excess of blasts in myelodysplastic syndromes.
- Long-term effects of recombinant human erythropoietin on bone marrow progenitor cells.
- End-stage renal Diseases in patients 75 and over: a new medical, socio-economical and ethical challenge.
- Erythropoietin-induced protein S deficiency and vena cava thrombosis.
- Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal Disease...
Schools
School Med State University
Graduate Hosp McPHahnemann U
Johns Hopkins Hospital
Institution St Louis De Gonzague
Johns Hopkins Bloomberg School Of Public Health
University Rene Descartes Paris V UFR CochinPort Royal
Procedures Preformed
- Biopsy
- Continuous Renal Replacement Therapy
- Hemodialysis
- Kidney Stones Treatment
- View All
Conditions Treated
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Fellow (ASNF)
Education
-
Johns Hopkins Bloomberg School of Public Health -
Johns Hopkins University -
Drexel University - Hahnemann University Hospital -
University of Haiti
Hospital
-
MedStar Good Samaritan Hospital -
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center
Drug Facts
| NPI NUMBER | 1962408617 | |
| NPPES Provider LastName | JAAR | |
| NPPES Provider FirstName | BERNARD | |
| NPPES Provider ZIPCode | 212392905 | |
| NPPES Provider State | MD | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1127.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962408617 |
| Last Name Of The Provider | JAAR |
| First Name Of The Provider | BERNARD |
| View All |
Similar Doctors
|
Dr. Rochelle M. Cunningham, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manju A. Mavanur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. Weinman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Steve Y. Shen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa J. Cohen, MD |
|
|
Dr. Joseph M. Nogueira, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul J. Scheel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khalid K. Al-Talib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hiba M. Barghouthi, MD |